Lisa Rarick Net Worth

The estimated Net Worth of Lisa Dale Rarick is at least $92 dollars as of 11 June 2021. Ms. Rarick owns over 5,000 units of Evofem Biosciences Inc stock worth over $92 and over the last 5 years he sold EVFM stock worth over $0. In addition, he makes $0 as Independent Director at Evofem Biosciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Rarick EVFM stock SEC Form 4 insiders trading

Lisa has made over 2 trades of the Evofem Biosciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of EVFM stock worth $6,000 on 11 June 2021.

The largest trade he's ever made was buying 5,250 units of Evofem Biosciences Inc stock on 17 June 2020 worth over $15,698. On average, Lisa trades about 1,708 units every 60 days since 2020. As of 11 June 2021 he still owns at least 10,250 units of Evofem Biosciences Inc stock.

You can see the complete history of Ms. Rarick stock trades at the bottom of the page.

Lisa Rarick biography

Dr. Lisa Dale Rarick M.D. serves as Independent Director of the Company. Dr. Rarick began her career at the FDA in 1988 as a Medical Officer, responsible for the management of products indicated for a variety of reproductive health conditions, including oral, transdermal and vaginal contraceptives. She became the Director for the Division of Reproductive and Urologic Products when it was formed in 1996, and later held several management roles in the Center for Drug Evaluation and Research (CDER), including Deputy Director of the Office of Drug Evaluation 2 and Associate Director in the Office of the Center Director. Her final year at the FDA was spent in the Office of Women’s Health, where she focused on HIV prevention, pregnancy prevention, pre- and post-pregnancy care and menopausal therapy. She is currently a reproductive health and regulatory affairs consultant who has helped numerous companies navigate the development of their products from early-stage development through FDA approval. Dr. Rarick received her B.S. and M.D. from the Loma Linda University School of Medicine and completed her residency training in Obstetrics and Gynecology at Georgetown University. She has been a member of the Scientific Advisory Committee for the National Institute of Child Health and Human Development since 2004 and served on the Board of Directors for Alliance Partners 360 from June 2017 - June 2019.

How old is Lisa Rarick?

Lisa Rarick is 60, he's been the Independent Director of Evofem Biosciences Inc since 2020. There are 5 older and 9 younger executives at Evofem Biosciences Inc. The oldest executive at Evofem Biosciences Inc is Gillian Greer, 75, who is the Independent Director.

What's Lisa Rarick's mailing address?

Lisa's mailing address filed with the SEC is C/O EVOFEM BIOSCIENCES, INC., 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130.

Insiders trading at Evofem Biosciences Inc

Over the last 7 years, insiders at Evofem Biosciences Inc have traded over $32,368,585 worth of Evofem Biosciences Inc stock and bought 12,978,479 units worth $54,857,186 . The most active insiders traders include Research Corp Acacia, Fund Solutions Ltd Link, eBiopharma, Inc. Pdl. On average, Evofem Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of $5,281. The most recent stock trade was executed by Yan Zhang on 12 January 2024, trading 104 units of EVFM stock currently worth $4.

What does Evofem Biosciences Inc do?

evofem is a biotechnology company focusing on developing innovative reproductive health products for women in every global market. evofem develops and markets products that are woman-controlled, non-invasive and rapidly reversible. women need access to effective products that are well suited to their lifestyle and consistent with their core values. products include: amphora™ - a non-hormonal vaginal gel being investigated for contraceptive and microbicidal properties.

Complete history of Ms. Rarick stock trades at Evofem Biosciences Inc

Evofem Biosciences Inc executives and stock owners

Evofem Biosciences Inc executives and other stock owners filed with the SEC include:

• Saundra Pelletier,
  President, Chief Executive Officer, Director
• Kelly Culwell,
  Chief Medical Officer
• Saundra Pelletier,
  Pres, CEO & Director
• Thomas Lynch,
  Chairman of the Board
• Russell Barrans,
  Chief Commercial Officer
• Justin File,
  Chief Financial Officer
• Justin J. File,
  Chief Financial Officer
• Russell Barrans,
  Chief Commercial Officer
• Tony O'Brien,
  Independent Director
• William Hall,
  Independent Director
• Colin Rutherford,
  Independent Director
• Gillian Greer,
  Independent Director
• Kim Kamdar,
  Independent Director
• Amy Raskopf,
  IR Contact Officer
• Lisa Rarick,
  Independent Director
• Alexander Fitzpatrick,
  Executive Vice President, General Counsel, Secretary
• Dr. Kelly Culwell M.D.,
  Chief Medical Officer
• Kathy Gallo-Doyle,
  VP of Sales
• Alexander A. Fitzpatrick Esq.,
  Exec. VP, Gen. Counsel & Sec.
• Biopharma, Inc. Pdl,
  10% owner
• Research Corp Acacia,
  10% owner
• Anthony Stephen O'brien,
  Director
• Yan Zhang,
  CFO
• Ltd. Invesco,
  10% owner
• Fund Solutions Ltd Link,
  10% owner